Medpace Holdings Raises 2026 EPS Guidance Above Consensus
Medpace Holdings (MEDP) has updated its financial outlook for 2026, raising its projected diluted GAAP earnings per share (EPS) range to between $17.97 and $18.32. This new guidance exceeds the current market consensus of $17.59 and represents an increase from the previous guidance range of $17.25 to $17.95. Despite the upward revision in profitability expectations, the company's full-year revenue outlook remains slightly conservative relative to analyst expectations. Medpace projects total revenue between $2.835 billion and $2.855 billion, placing the midpoint of this range just below the consensus estimate of $2.85 billion.
Tickers: $MEDP